Related Experiment Video
Updated: Jun 12, 2026
06:03
Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
Published on: June 11, 2020
Nanomicelle-Based Multi-mRNA Delivery Promotes Cardiac Repair After Myocardial Infarction
Kazuma Handa1, Takuji Kawamura1, Yasunobu Mano2,3
1Department of Cardiovascular Surgery The University of Osaka Graduate School of Medicine Osaka Japan.
Small Science
|June 11, 2026
Summary
Synthetic messenger RNA (mRNA) therapy using a combination of five genes effectively regenerated heart tissue, improved cardiac function, and extended survival in a mouse model of myocardial infarction (MI). This combinatorial mRNA approach offers a promising new treatment for heart failure.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Molecular Therapy
Background:
- Pathological cardiac remodeling after myocardial infarction (MI) is complex and requires multifaceted therapeutic strategies.
- Synthetic messenger RNAs (mRNAs) offer a flexible platform for combinatorial gene delivery.
- Extracellular vesicles from cardiomyocytes have previously shown potential in restoring cardiac function.
Purpose of the Study:
- To investigate the therapeutic potential of a synthetic mRNA cocktail for treating post-MI heart failure.
- To evaluate the efficacy of delivering five specific therapeutic genes via polyplex nanomicelles directly into the myocardium.
- To elucidate the molecular mechanisms underlying mRNA cocktail-mediated cardiac repair.
Main Methods:
- Synthetic mRNAs encoding five selected genes (Hgf, Igf1, Pdgfb, Cxcl12, Tgfβ1) were formulated into polyplex nanomicelles.
- Direct myocardial administration of mRNA nanomicelles in a mouse model of MI-induced heart failure.
- Analysis of molecular pathways including PI3K-Akt-ETV4, JNK/FOXO3, and ERK signaling.
Main Results:
- The mRNA cocktail treatment promoted angiogenesis via the PI3K-Akt-ETV4 pathway.
- Fibrosis was suppressed through inhibition of the JNK/FOXO3 pathway.
- Cardiac repair and regeneration were enhanced by activating ERK signaling, leading to improved contractility and survival.
Conclusions:
- Multigene synthetic mRNA cocktail therapy demonstrates significant therapeutic potential for post-MI heart failure.
- Polyplex nanomicelles facilitate effective local delivery and sustained expression of therapeutic mRNAs.
- This approach represents a novel strategy for treating complex cardiac remodeling and offers a step towards new interventions for heart disease.
